Related Experiment Video
Updated: Apr 21, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as
Deepak K Kadayakkara1, Michael J Korrer1, Jeff W M Bulte2
1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins School of Medicine, Baltimore, Maryland. Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins School of Medicine, Baltimore, Maryland.
Noninvasive imaging combining MRI and bioluminescence imaging (BLI) tracks vaccine immune responses. Glucopyranosyl lipid A (GLA) adjuvant altered immune cell migration but enhanced T-cell proliferation and tumor therapy.
Area of Science:
- Immunology
- Biomedical Imaging
- Vaccinology
Background:
- Evaluating cell-mediated immunity post-vaccination typically requires invasive methods.
- Noninvasive imaging offers a longitudinal approach to study immune responses.
Purpose of the Study:
- To assess the utility of combined MRI and BLI for longitudinally visualizing vaccine-induced immune responses.
- To evaluate the impact of glucopyranosyl lipid A (GLA) as a vaccine adjuvant on immune cell dynamics and therapeutic efficacy.
Main Methods:
- Utilized magnetic resonance imaging (MRI) for visualizing antigen-presenting cell migration and bioluminescence imaging (BLI) for tracking T-cell responses.
- Employed a whole-cell tumor vaccine with glucopyranosyl lipid A (GLA) adjuvant in animal models.
- Confirmed imaging findings with flow cytometry.
Main Results:
- MRI revealed that GLA incorporation reduced antigen capture and migration to draining lymph nodes (DLN).
- BLI demonstrated a correlation between antigen delivery to DLN and T-cell response magnitude.
- Despite reduced DLN antigen delivery, GLA significantly enhanced T-cell proliferation in the spleen and improved tumor therapy.
Conclusions:
- Combined MRI and BLI provide a powerful noninvasive tool for evaluating vaccine responses.
- GLA adjuvant modulates the temporal and anatomical characteristics of both afferent and efferent immune arms.
- GLA enhances vaccine efficacy through mechanisms independent of initial antigen presentation in DLN.
Related Concept Videos
Tumor Immunotherapy
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

